The Cannabigerol Derivative VCE-003.2 Exerts Therapeutic Effects in 6-Hydroxydopamine-Lesioned Mice: Comparison with The Classic Dopaminergic Replacement Therapy.

EHP-102 - Emerald Health Pharmaceuticals

http://www.ncbi.nlm.nih.gov/pubmed/37759872

Eduardo Muñoz; Elisa Navarro; Javier Fernández-Ruiz; Santiago Rodríguez-Carreiro

Sep 28, 2023